Immunocore Holdings (IMCR) Current Taxes (2019)
Immunocore Holdings' (IMCR) quarterly Current Taxes came in at $92572.2 in Q4 2019.
Immunocore Holdings (IMCR) Current Taxes (2019) Analysis & Trends
Immunocore Holdings has disclosed Current Taxes across 1 years of filings, most recently posting $92572.2 for Q4 2019.
- Current Taxes for Q4 2019 came in at $92572.2, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $92572.2 (changed N/A YoY), and the FY2019 annual result was $92572.2, changed N/A from the prior year.
- Current Taxes came in at $92572.2 for Q4 2019 at Immunocore Holdings.
- In the past five years, Current Taxes ranged from a high of $92572.2 in Q4 2019 to a low of $92572.2 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 10,460.56 |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | - |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 92,572.19 |